FDA facility inspections ensure drugs and medical devices are made safely and consistently. Learn how risk-based inspections, Form 483, and data integrity checks protect public health - and how manufacturers can prepare.
February 26 2026
Clinicians are raising alarms over generic drug quality as manufacturing shifts overseas. With 54% higher adverse events linked to Indian-made generics, questions are growing about safety, oversight, and the real cost of cheap medicine.
January 19 2026